Dinesh Kundu | CEO & Co-Founder
East Ocyon Bio

Dr. Dinesh Kundu is the Co-Founder & CEO of East Ocyon Bio, India’s first allogeneic cell-therapy company developing off-the-shelf NK and γδT cell therapies for solid tumours, autoimmune and rare diseases. A physician and biotech entrepreneur with 15+ years’ experience across translational R&D and biomanufacturing, he is building an integrated R&D-to-GMP platform in Gurugram to deliver globally compliant yet affordable therapies for underserved populations. His team combines feeder-free expansion, gamma-retroviral vector engineering and robust potency analytics to accelerate IND-enabling studies in India. Dr. Kundu collaborates widely with leading institutes and CROs and advocates regulatory harmonisation for CGT across India and the GCC.